RxDoctor Payments Data

Arya Namin, MD

Otolaryngology · Saint Louis, MONPI 1023419405

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,741 of the $4,290 with a category attached, or 87.2%. 21 manufacturers reported payments, led by Lumenis BE Inc at 35.0% of the total. Reporting peaked in 2022 at $2,007 and has fallen 55.5% since, to $894 in 2025.

$4,290in general payments, 2019–2025

Across 49 payments — averaging $87.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lumenis BE Inc$2K
  • Stryker$1K
  • Johnson & Johnson$367
  • Organogenesis Inc.$326
  • Inspire Medical Systems, Inc.$137
  • Axogen$124
  • plus $692 from 15 others

What the payments were for

  • Travel & lodging$2646%
  • Food & beverage$3,74187%
  • Education$2867%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,290 in reported general payments places this provider in the 85th percentile of 210 otolaryngology providers in Missouri.

See all otolaryngology providers in Missouri

Medicare billing

Part B allowed, 2024
$105,607
Medicare patients
132
Services billed
504

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RyaltrisOlopatadine Hcl/Mometasone12$2,920
Ipratropium Bromide62$1,480
Azelastine Hcl72$1,455
Doxycycline Hyclate22$406
Mupirocin56$369
Clindamycin Hcl22$262
Fluticasone Propionate21$254
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav28$240
Amitriptyline Hcl21$165
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$154
Cephalexin24$122
Ondansetron OdtOndansetron16$88
Prednisone33$43
Levothyroxine Sodium12$23

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →